Replimune Group Inc (REPL)

Healthcare | Biotechnology
Income Statement (Quarterly) 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue 0 0 0 0
Cost of Revenue 1,665,000 -736,000 0 0
Gross Profit -1,665,000 736,000 0 0
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 32,579,000 24,302,000 18,015,000 15,468,000
Operating Expenses 90,422,000 79,325,000 66,019,000 58,916,000
Operating Income -90,422,000 -79,325,000 -66,019,000 -58,916,000
Interest Expense 1,996,000 -8,025,000 1,978,000 1,969,000
Income Before Tax -86,693,000 -74,237,000 -65,765,000 -53,055,000
Income Tax Expense -420,000 739,000 575,000 -408,000
Net Income -86,693,000 -74,130,000 -66,340,000 -53,055,000
Per Share
EPS -0.95 -0.82 -0.79 -0.68
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Revenue 0 0 0 0 0
Cost of Revenue 3,502,000 2,655,000 2,447,000 4,575,000 0
Gross Profit -3,502,000 -2,655,000 -2,447,000 -4,575,000 0
Operating Expenses
R&D Expenses 0 0 0 0 0
SG&A Expenses 72,180,000 59,810,000 50,553,000 38,769,000 23,201,000
Operating Expenses 261,627,000 234,773,000 174,166,000 115,144,000 79,955,000
Operating Income -261,627,000 -234,773,000 -177,080,000 -118,314,000 -79,955,000
Interest Expense 7,893,000 6,660,000 4,160,000 2,223,000 3,060,000
Income Before Tax -246,829,000 -215,386,000 -173,996,000 -118,036,000 -80,870,000
Income Tax Expense 468,000 408,000 288,000 1,164,000 0
Net Income -247,297,000 -215,794,000 -174,284,000 -118,036,000 -80,870,000
Per Share
EPS -3.07 -3.24 -2.99 -2.26 -1.75
EPS Diluted 0.00 0.00 0.00 0.00 0.00
Balance Sheet (Quarterly) 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Assets
Cash and Cash Equivalents 111,119,000 74,457,000 146,590,000 105,948,000
Short Term Investments 372,685,000 346,211,000 436,796,000 289,707,000
Net Receivables 3,725,000 4,922,000 2,939,000 3,055,000
Inventory 0 0 0 0
Total Current Assets 495,880,000 433,667,000 592,603,000 403,977,000
Property Plant Equipment 52,545,000 52,355,000 52,352,000 55,579,000
Goodwill and Intangibles 0 0 0 0
Total Assets 551,328,000 487,722,000 646,591,000 461,192,000
Liabilities
Account Payables 12,463,000 2,578,000 5,364,000 3,732,000
Short Term Debt 3,983,000 3,879,000 3,757,000 3,632,000
Total Current Liabilities 62,362,000 40,438,000 33,825,000 20,756,000
Long Term Debt 72,182,000 71,990,000 57,002,000 29,207,000
Total Liabilities 135,485,000 113,214,000 91,299,000 49,963,000
Shareholders Equity
Retained Earnings -948,579,000 -701,282,000 -485,488,000 -311,204,000
Total Shareholders Equity 415,843,000 374,508,000 555,292,000 411,229,000
Balance Sheet (Annual) 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Assets
Cash and Cash Equivalents 111,119,000 74,457,000 146,590,000 105,948,000 182,518,000
Short Term Investments 372,685,000 346,211,000 436,796,000 289,707,000 293,784,000
Net Receivables 3,725,000 4,922,000 2,939,000 3,055,000 2,953,000
Inventory 0 0 0 0 0
Total Current Assets 495,880,000 433,667,000 592,603,000 403,977,000 483,747,000
Property Plant Equipment 52,545,000 52,355,000 52,352,000 55,579,000 57,715,000
Goodwill and Intangibles 0 0 0 0 0
Total Assets 551,328,000 487,722,000 646,591,000 461,192,000 543,098,000
Liabilities
Account Payables 12,463,000 2,578,000 5,364,000 3,732,000 2,355,000
Short Term Debt 3,983,000 3,879,000 3,757,000 3,632,000 3,457,000
Total Current Liabilities 62,362,000 40,438,000 33,825,000 20,756,000 14,547,000
Long Term Debt 72,182,000 71,990,000 57,002,000 29,207,000 29,823,000
Total Liabilities 135,485,000 113,214,000 91,299,000 49,963,000 44,370,000
Shareholders Equity
Retained Earnings -948,579,000 -701,282,000 -485,488,000 -311,204,000 -193,168,000
Total Shareholders Equity 415,843,000 374,508,000 555,292,000 411,229,000 498,728,000
Cash Flow Statement (Quarterly) 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Operating Activities
Net Income -247,297,000 -215,794,000 -174,284,000 -118,036,000
Depreciation & Amortization 3,502,000 2,655,000 2,447,000 2,147,000
Stock Based Compensation 35,044,000 34,125,000 28,131,000 24,254,000
Change in Working Capital 24,081,000 5,483,000 15,124,000 7,235,000
Operating Cash Flow -192,250,000 -185,467,000 -128,050,000 -82,180,000
Investing Activities
Capital Expenditure -6,687,000 -5,662,000 -2,270,000 -2,336,000
Investments -6,687,000 -5,662,000 -2,270,000 -2,336,000
Investing Cash Flow -23,796,000 97,201,000 -142,502,000 -1,806,000
Financing Activities
Debt Repayment -599,000 14,524,000 -365,000 -264,000
Common Stock Issued/Repurchased 155,728,000 1,759,000 187,292,000 6,862,000
Dividends Paid 0 0 0 0
Financing Cash Flow 252,396,000 16,283,000 311,303,000 6,598,000
Summary
Free Cash Flow -198,937,000 -191,129,000 -130,320,000 -84,516,000
Net Change in Cash 36,665,000 -72,069,000 40,642,000 -76,570,000
Cash Flow Statement (Annual) 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Operating Activities
Net Income -247,297,000 -215,794,000 -174,284,000 -118,036,000 -80,870,000
Depreciation & Amortization 3,502,000 2,655,000 2,447,000 2,147,000 1,711,000
Stock Based Compensation 35,044,000 34,125,000 28,131,000 24,254,000 11,790,000
Change in Working Capital 24,081,000 5,483,000 15,124,000 7,235,000 3,510,000
Operating Cash Flow -192,250,000 -185,467,000 -128,050,000 -82,180,000 -61,389,000
Investing Activities
Capital Expenditure -6,687,000 -5,662,000 -2,270,000 -2,336,000 -2,392,000
Investments -6,687,000 -5,662,000 -2,270,000 -2,336,000 -2,392,000
Investing Cash Flow -23,796,000 97,201,000 -142,502,000 -1,806,000 -188,776,000
Financing Activities
Debt Repayment -599,000 14,524,000 -365,000 -264,000 -10,145,000
Common Stock Issued/Repurchased 155,728,000 1,759,000 187,292,000 6,862,000 286,107,000
Dividends Paid 0 0 0 0 0
Financing Cash Flow 252,396,000 16,283,000 311,303,000 6,598,000 372,462,000
Summary
Free Cash Flow -198,937,000 -191,129,000 -130,320,000 -84,516,000 -63,781,000
Net Change in Cash 36,665,000 -72,069,000 40,642,000 -76,570,000 123,018,000